Angiogenic inhibitory compounds
US6426067B1 · kind B1 · utility
9Cited by
7References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 1999 |
| Grant date | Jul 30, 2002 |
| Priority date | — |
| Expiry date | Mar 22, 2019 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
For proposes of prophylactic or treatment of diseases related to inappropriate angiogenesis, a compound can be administered that is (i) a linear, non-carbohydrate polymer having a plurality of side chain groups or (ii) a dendrimer having a plurality of terminal groups. At least one of the side chain groups of the linear, non-carbohydrate polymer has an anionic- or cationic-containing moiety bonded or linked thereto. The plurality of terminal groups of the dendrimer has at least one anionic- or cationic-containing moiety bonded or linked thereto.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.